
Eli Lilly stock rises as Retatrutide data boosts obesity drug lead
Shares of Eli Lilly LLY climbed about 4% on Monday after the drugmaker unveiled encouraging new clinical data for its next-generation obesity treat...

Goldman Sachs reveals its top non-AI stocks
The artificial intelligence (AI) boom continues to set the direction for global financial markets in 2026, but Goldman Sachs strategists argue that...